The study shows that frequent use of high-potency cannabis alters DNA, affecting genes related to energy and immune function. These changes differ between those with and without psychosis, suggesting cannabis use could influence mental health through biological pathways.
According to new research from the Institute of Psychiatry, Psychology & Neuroscience at King’s College London and the University of Exeter, the use of high-potency cannabis leaves a unique imprint on DNA.
Published in Molecular Psychiatry, this is the first study to suggest that the use of high-potency cannabis leaves a distinct mark on DNA, providing valuable insights into the biological impact of cannabis use. High-potency cannabis is defined as having Delta-9-tetrahydrocannabinol (THC) content of 10 percent or more.
The research also showed the effect of cannabis use on DNA is different in people experiencing their first episode of psychosis compared to users who have never experienced psychosis, suggesting there could be potential for DNA blood tests to help characterize those cannabis users at risk of developing psychosis to inform preventative approaches.
The study was funded by the Medical Research Council, the National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre (BRC), and the NIHR Exeter BRC.
Senior author Marta Di Forti, Professor of Drugs, Genes, and Psychosis at King’s IoPPN said: “With the increasing prevalence of cannabis use and more availability of high potency cannabis, there is a pressing need to better understand its biological impact, particularly on mental health. Our study is the first to show that potency cannabis leaves a unique signature on DNA related to mechanisms around the immune system and energy production. Future research needs to explore if the DNA signature for current cannabis use, and in particular the one of high potency types, can help identify those users most at risk to develop psychosis, both in recreational and medicinal use settings.”
Research Focus on DNA Methylation
Researchers explored the effects of cannabis use on DNA methylation – a chemical process detected in blood samples that alters how genes are functioning (whether they are switched ‘on’ or ‘off’). DNA methylation is a type of epigenetic change, which means it alters gene expression without affecting the DNA sequence itself and is considered a vital factor in the interplay between risk factors and mental health.
The laboratory team at the University of Exeter conducted complex analyses of DNA methylation across the whole human genome using blood samples from both people who have experienced first-episode psychosis and those who have never had a psychotic experience. The researchers investigated the impact of current cannabis use, including frequency and potency, on the DNA of a total of 682 participants
Key Findings on Gene Function
The analysis showed that frequent users of high-potency cannabis had changes in genes related to mitochondrial and immune function, particularly the CAVIN1 gene, which could affect energy and immune response. These changes were not explained by the well-established impact that tobacco has on DNA methylation, which is usually mixed into joints by most cannabis users.
Dr. Emma Dempster, Senior Lecturer at the University of Exeter and the study’s first author, said: “This is the first study to show that frequent use of high-potency cannabis leaves a distinct molecular mark on DNA, particularly affecting genes related to energy and immune function. Our findings provide important insights into how cannabis use may alter biological processes. DNA methylation, which bridges the gap between genetics and environmental factors, is a key mechanism that allows external influences, such as substance use, to impact gene activity. These epigenetic changes, shaped by lifestyle and exposures, offer a valuable perspective on how cannabis use may influence mental health through biological pathways.”
Dr. Emma Dempster meta-analyzed data from two cohorts: the GAP study, which consists of patients with first-episode psychosis in South London and Maudsley NHS Foundation Trust, and the EU-GEI study, which consists of patients with first-episode psychosis and healthy controls across England, France, the Netherlands, Italy, Spain, and Brazil. This totaled 239 participants with first-episode psychosis and 443 healthy controls representing the general population from both studies sites who had available DNA samples.
Most of the cannabis users in the study used high-potency cannabis more than once a week (defined as frequent use) and had first used cannabis at age 16 years old, on average. High potency cannabis was defined as having Delta-9-tetrahydrocannabinol (THC) content of 10 percent or greater. THC is the principal psychoactive constituent in cannabis.
Reference: “Methylomic signature of current cannabis use in two first-episode psychosis cohorts” by Emma L. Dempster, Chloe C. Y. Wong, Joe Burrage, Eilis Hannon, Diego Quattrone, Giulia Trotta, Victoria Rodriguez, Luis Alameda, Edoardo Spinazzola, Giada Tripoli, Isabelle Austin-Zimmerman, Zhikun Li, Charlotte Gayer-Anderson, Tom P. Freeman, Emma C. Johnson, Hannah E. Jongsma, Simona Stilo, Caterina La Cascia, Laura Ferraro, Daniele La Barbera, Antonio Lasalvia, Sarah Tosato, Ilaria Tarricone, Giuseppe D’Andrea, Michela Galatolo, Andrea Tortelli, Maurizio Pompili, Jean-Paul Selten, Lieuwe de Haan, Paulo Rossi Menezes, Cristina M. Del Ben, Jose Luis Santos, Manuel Arrojo, Julio Bobes, Julio Sanjuán, Miguel Bernardo, Celso Arango, Peter B. Jones, Gerome Breen, Valeria Mondelli, Paola Dazzan, Conrad Iyegbe, Evangelos Vassos, Craig Morgan, Diptendu Mukherjee, Jim van Os, Bart Rutten, Michael C. O’Donovan, Pak Sham, Jonathan Mill, Robin Murray and Marta Di Forti, 16 October 2024, Molecular Psychiatry.
DOI: 10.1038/s41380-024-02689-0
Funding: Medical Research Council, NIHR Maudsley Biomedical Research Centre
News
3D-printed implant offers a potential new route to repair spinal cord injuries
A research team at RCSI University of Medicine and Health Sciences has developed a 3-D printed implant to deliver electrical stimulation to injured areas of the spinal cord, offering a potential new route to [...]
Nanocrystals Carrying Radioisotopes Offer New Hope for Cancer Treatment
The Science Scientists have developed tiny nanocrystal particles made up of isotopes of the elements lanthanum, vanadium, and oxygen for use in treating cancer. These crystals are smaller than many microbes and can carry isotopes of [...]
New Once-a-Week Shot Promises Life-Changing Relief for Parkinson’s Patients
A once-a-week shot from Australian scientists could spare people with Parkinson’s the grind of taking pills several times a day. The tiny, biodegradable gel sits under the skin and releases steady doses of two [...]
Weekly injectable drug offers hope for Parkinson’s patients
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the University of South Australia [...]
Most Plastic in the Ocean Is Invisible—And Deadly
Nanoplastics—particles smaller than a human hair—can pass through cell walls and enter the food web. New research suggest 27 million metric tons of nanoplastics are spread across just the top layer of the North [...]
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]
AI matches doctors in mapping lung tumors for radiation therapy
In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue. But this process, called [...]
Scientists Finally “See” Key Protein That Controls Inflammation
Researchers used advanced microscopy to uncover important protein structures. For the first time, two important protein structures in the human body are being visualized, thanks in part to cutting-edge technology at the University of [...]
